https://pipelinereview.com/SELLAS-Announces-Completion-of-Enrollment-in-Randomized-Phase-2-VADIS-Trial-of-Nelipepimut-S-NPS-in-Women-with-Ductal-Carcinoma-In-Situ-DCIS-of-the-Breast/